Real-time enrollment status for this diabetes mellitus, type 2 clinical trial
Current Status
Recruiting
Checked: November 6, 2026 at 10:31 AM UTC
| NCT Number | NCT07866066 |
| Recruiting Status | Recruiting |
| Condition | Diabetes Mellitus, Type 2 |
| Phase | PHASE3 |
| Target Enrollment | 1,300 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | November 5, 2026 (Yesterday) |
As of November 6, 2026: Clinical trial NCT07866066 is currently recruiting participants. This phase3 study for diabetes mellitus, type 2 is actively seeking new participants at 7 locations across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07866066 is actively recruiting participants as of November 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07866066 was last updated Yesterday (November 5, 2026). HelloStudys verifies this status automatically.